Sentences with phrase «at cancer research centers»

«That's just the nature of a big company,» says Richon, whose 28 - year career has included roles at cancer research centers and Merck (mrk).

«Salmonella strains have a natural preference for infiltrating and replicating within the cancer cells of a tumor, making the bacteria an ideal candidate for bacteriotherapy,» said Robert Kazmierczak, a senior investigator at the Cancer Research Center and a post-doctoral fellow in the Division of Biological Sciences in the MU College of Arts and Science.

The collection contains over 20,000 different samples of Salmonella, with half of the samples housed at the Cancer Research Center where researchers affiliated with MU focus on three areas of cancer research: early detection, targeted treatment and new, effective chemotherapy.

Now, scientists at the Cancer Research Center and the University of Missouri have developed a non-toxic strain of Salmonella to penetrate and target cancer cells.

Kazmierczak and the team at the Cancer Research Center (CRC) developed CRC2631, a Salmonella strain that has been genetically modified to render the bacteria nontoxic and enhance its natural ability to target and kill cancer cells — without harming normal, healthy cells.

How did an expert in organic synthesis end up at a cancer research center?

Not exact matches

And when Ziskin's breast cancer had reemerged with brutal efficiency after a long remission, Parker had managed to get her into a last - ditch immunotherapy protocol at the Hutch, the famed Fred Hutchinson Cancer Research Center in Seattle — chartering private planes at his own expense to shepherd her back and forth from Los Ancancer had reemerged with brutal efficiency after a long remission, Parker had managed to get her into a last - ditch immunotherapy protocol at the Hutch, the famed Fred Hutchinson Cancer Research Center in Seattle — chartering private planes at his own expense to shepherd her back and forth from Los AnCancer Research Center in Seattle — chartering private planes at his own expense to shepherd her back and forth from Los Angeles.

Memorial donations may be made in honour of Shawn Price to the Cancer Center of Melanoma Research at CPMC Sutter Health Foundation: www.cpmc.org/giving.

IBM has already struck prominent collaborative arrangements with major cancer research centers like those at the Broad Institute of MIT and Harvard.

It's a two - day, tri-county cycling event that donates 100 % of rider - raised funds to innovative cancer research at the University of Miami Sylvester Comprehensive Cancer Ccancer research at the University of Miami Sylvester Comprehensive Cancer CCancer Center.

At Nationwide Children's, we help kids everywhere and provide life - saving research and care in Cancer, NICU, The Heart Center, Muscular Dystrophy and all of our nationally ranked clinical programs.

«It is a huge reduction in risk,» says Amanda Phipps, a pre-doctoral research associate at the Fred Hutchinson Cancer Research Center in Seattle, of the nearly 60 % decreased risk in women who breastfeed and have a family history of breastresearch associate at the Fred Hutchinson Cancer Research Center in Seattle, of the nearly 60 % decreased risk in women who breastfeed and have a family history of breast cCancer Research Center in Seattle, of the nearly 60 % decreased risk in women who breastfeed and have a family history of breastResearch Center in Seattle, of the nearly 60 % decreased risk in women who breastfeed and have a family history of breast cancercancer.

Pete has supported legislation to increase Medicare reimbursements for screening and diagnostic mammographies; fund research centers to study the relationship between the environment and breast cancer; and require insurance companies to guarantee at least 48 hours hospital care after a mastectomy.»

The doctor at the center of the Silver scandal «disapproved» of him and his law firm and referred cancer patients there only as long as the former speaker was funneling him state money for research, the court papers claim.

At 10 a.m., LG Kathy Hochul delivers remarks at a Roswell Park Cancer Institute announcement, Research Studies Center, Gaylord / Cary Meeting Rooms, Elm & Carlton streets, BuffalAt 10 a.m., LG Kathy Hochul delivers remarks at a Roswell Park Cancer Institute announcement, Research Studies Center, Gaylord / Cary Meeting Rooms, Elm & Carlton streets, Buffalat a Roswell Park Cancer Institute announcement, Research Studies Center, Gaylord / Cary Meeting Rooms, Elm & Carlton streets, Buffalo.

The doctor at the center of the corruption charges against former Assembly Speaker Sheldon Silver «disapproved» of him and his law firm and referred cancer patients there only as long as Silver was funneling him state money for research, new court papers claim.

But like many core facility directors, Potter also has the chance to use the equipment to conduct research, a privilege also enjoyed by Ralph J. Garippa, director of the RNAi Core Facility at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City.

«Our study suggests that epigenetic changes to cells treated with cigarette smoke sensitize airway cells to genetic mutations known to cause lung cancers,» says Stephen Baylin, M.D., the Virginia and D.K. Ludwig Professor for Cancer Research and professor of oncology at the Johns Hopkins Kimmel Cancer Center.

Cancer research is at an «inflection point» where scientists must adapt to new ways of sharing data and putting patients at the center of care, said former Vice President Joseph R. Biden, Jr. at the 2018 AAAS Annual Meeting.

Today, Mangahas, who before entering the wine world worked in cancer research at the Fred Hutchinson Cancer Research Center in Seattle, Washington, and at Princeton University, directs all aspects of the winemaking process at Hartford Family Winery, from deciding when to harvest grapes to selecting barrels and overseeing fermentcancer research at the Fred Hutchinson Cancer Research Center in Seattle, Washington, and at Princeton University, directs all aspects of the winemaking process at Hartford Family Winery, from deciding when to harvest grapes to selecting barrels and overseeing fermeresearch at the Fred Hutchinson Cancer Research Center in Seattle, Washington, and at Princeton University, directs all aspects of the winemaking process at Hartford Family Winery, from deciding when to harvest grapes to selecting barrels and overseeing fermentCancer Research Center in Seattle, Washington, and at Princeton University, directs all aspects of the winemaking process at Hartford Family Winery, from deciding when to harvest grapes to selecting barrels and overseeing fermeResearch Center in Seattle, Washington, and at Princeton University, directs all aspects of the winemaking process at Hartford Family Winery, from deciding when to harvest grapes to selecting barrels and overseeing fermentation.

After graduating in 1993, Mangahas went to work as a lab technician at the Fred Hutchinson Cancer Research Center, managing the laboratory of Virginia Zakian and conducting research using common baker's yeast — the same yeast he uses today to fermeResearch Center, managing the laboratory of Virginia Zakian and conducting research using common baker's yeast — the same yeast he uses today to fermeresearch using common baker's yeast — the same yeast he uses today to ferment wine.

He completed his neurology residency at Walter Reed Army Medical Center, conducted further studies under a neuropharmacology research fellowship at Sloan - Kettering Cancer Center, and completed a neurointensive care fellowship at Johns Hopkins Hospital.

«We're trying to build models that describe how tumors grow and respond to therapy,» said Yankeelov, director of the Center for Computational Oncology at The University of Texas at Austin (UT Austin) and director of Cancer Imaging Research in the LIVESTRONG Cancer Institutes of the Dell Medical School.

«Cancer research is a high priority for both countries — just witness the launch of a new National Cancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cCancer research is a high priority for both countries — just witness the launch of a new National Cancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cCancer Moonshot initiative in the United States early this year,» said Tom Wang, chief international officer at AAAS and director of the AAAS center, referring to the plan President Barack Obama unveiled earlier this year to direct $ 1 billion toward battling cancercancer.

«This research represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author of the companion study inresearch represents a big step forward in understanding why some tumors are more aggressive than others and being able to predict rationally which neoantigens will be the most effective at stimulating an immune response,» said Dr. Balachandran, a member of the David M. Rubenstein Center for Pancreatic Cancer Research at MSK, and corresponding author of the companion study inResearch at MSK, and corresponding author of the companion study in Nature.

Dr. Greenbaum and Dr. Łksza also played an integral role in a companion piece of research led by researchers Vinod P. Balachandran, MD, Taha Merghoub, PhD, and Steven D. Leach, MD, at Memorial Sloan Kettering Cancer Center (MSK) that was also published in Nature today.

«Our findings suggest that teens and young adults who seek indoor tanning may be especially vulnerable to developing BCC, the most common form of skin cancer, at a young age,» said lead author Professor Margaret Karagas, co-director of the Cancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at Dartcancer, at a young age,» said lead author Professor Margaret Karagas, co-director of the Cancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at DartCancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at DartCancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at Dartmouth.

asks David Maloney, an oncologist and immunotherapist at the Fred Hutchinson Cancer Research Center in Seattle.

L. H. Hartwell, P. Szankasi, and S. H. Friend are at the Seattle Project, Molecular Pharmacology Department, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

This is the main finding of new research led by investigators at NYU Langone Medical Center and its Perlmutter Cancer Center and published online May 19 in the Journal of the National Cancer Institute.

«Several major advances in recent years have been good news for multiple myeloma patients, but those new drugs only target terminally differentiated cancer cells and thus can only reduce the bulk of the tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego Hcancer cells and thus can only reduce the bulk of the tumor,» said Jamieson, who is also deputy director of the Sanford Stem Cell Clinical Center, director of the CIRM Alpha Stem Cell Clinic at UC San Diego and director of stem cell research at Moores Cancer Center at UC San Diego HCancer Center at UC San Diego Health.

Judith Gasson, senior associate dean for research at the David Geffen School of Medicine at UCLA and director of the Jonsson Cancer Center, said researchers have long hoped to develop an effective and lasting immunotherapy to fight cCancer Center, said researchers have long hoped to develop an effective and lasting immunotherapy to fight cancercancer.

Satoshi Tanaka arrived from the northern Japanese town of Sapporo to work as a postdoc at the German Cancer Research Center in Heidelberg (DKFZ) in 1999.

The Czech - born psychiatrist conducted dozens of government - sanctioned LSD experiments in the»50s,»60s, and early»70s on heroin addicts, alcoholics, and terminal cancer patients in his native Prague and later at the Maryland Psychiatric Research Center, a mental health facility in Catonsville, Maryland, where he was chief of psychiatric rResearch Center, a mental health facility in Catonsville, Maryland, where he was chief of psychiatric researchresearch.

This work was supported by the Carney Family Charitable Foundation, the National Cancer Institute's SPORE in Breast Cancer at Dana - Farber / Harvard Cancer Center (grant P50CA168504), STIMIT Corporation, and the Claudia Adams Barr Program for Innovative Cancer Research.

Led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), the retrospective study suggested that a pattern of molecules called microRNA (miRNA) in tumor cells might predict patients» response to radiation therapy.

At the Fred Hutchinson Cancer Research Center (FHCRC), there has been a strong center - driven effort to provide resources for interdisciplinary research training, such as establishing the Joint Degree and Dual Mentor pResearch Center (FHCRC), there has been a strong center - driven effort to provide resources for interdisciplinary research training, such as establishing the Joint Degree and Dual Mentor proCenter (FHCRC), there has been a strong center - driven effort to provide resources for interdisciplinary research training, such as establishing the Joint Degree and Dual Mentor procenter - driven effort to provide resources for interdisciplinary research training, such as establishing the Joint Degree and Dual Mentor presearch training, such as establishing the Joint Degree and Dual Mentor programs.

An experimental drug in early development for aggressive brain tumors can cross the blood - brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).

In our work at the Science Education Partnership (SEP) at the Fred Hutchinson Cancer Research Center (FHCRC), our goal is to provide professional development opportunities for high school science teachers.

Now, researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a personalized tool that can predict the likelihood of prostate cancer over-diagCancer Research Center and the University of Washington have developed a personalized tool that can predict the likelihood of prostate cancer over-diagcancer over-diagnosis.

A new study by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibCancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibCancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) has identified a mechanism by which cancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibcancer cells develop resistance to a class of drugs called fibroblast growth factor receptor (FGFR) inhibitors.

International collaborators are located at Centre Leon Berard, Centre Antoine Lacassagne, and Institut Gustave Roussy, all in France; Fondazione IRCCS Istituto Nazionale Tumori, in Italy; The Institute of Cancer Research, in the United Kingdom; University Hospital Essen, in Germany; and National Cancer Center Hospital East and Kobe University Hospital, both in Japan.

A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cCancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM - 398, given in combination with 5 - flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously - treated pancreatic cancercancer.

«It will be much more powerful than the antibodies,» says Timothy Chan, who does clinical research in immunotherapy at Memorial Sloan Kettering Cancer Center in New York City.

In collaboration with Prof. Dr. Roland Schüle and his team at the Center of Clinical Research of the Freiburg University Medical Center, the scientists were able to test several epigenetic inhibitors that had been newly developed by Schüle and his team on the cancer stem cell model.

Greg Finak, a senior staff scientist at the Fred Hutchinson Cancer Research Center in Seattle, Washington, describes his role as a «mini-faculty» member.

«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Mocancer, 90 percent of HPV - related vulvar and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Mocancer, 70 to 85 percent of high - grade cervical disease in females, and approximately 90 percent of HPV - related anal cancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Mocancer and genital warts in males and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at MoCancer at Moffitt.

Until now, EGFR inhibitors have only been effective at treating the 10 to 15 percent of non-small cell lung cancers that have a variant of EGFR, but the two - drug combo could potentially work for all non-small cell lung cancers, explained Dr. John Minna, Director of the Hamon Center for Therapeutic Oncology Research and Professor of Internal Medicine and Pharmacology.

Allison, chair of the immunology department at the University of Texas M.D. Anderson Cancer Center in Houston and executive director of its research center on immunotherapy, spoke with Scientific American about the future prospects and limitations of immunothCenter in Houston and executive director of its research center on immunotherapy, spoke with Scientific American about the future prospects and limitations of immunothcenter on immunotherapy, spoke with Scientific American about the future prospects and limitations of immunotherapy.

UTSW co-authors include: Co-lead author Maria Winter, a research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Dresearch technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver DResearch, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Diseases.